Clinical Trial Update: Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dosage of Vigamox eye drops administered prior to intravitreal injections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intravitreal Injection-related Complications

Drugs mentioned

• VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Illinois Retina Associates | Conditions: Intravitreal Injection Patients | Phase 4 | Status: COMPLETED